Laboratory Corporation of America Holdings is Scheduled to Present at the Bank of America 2008 Specialty Pharmaceuticals Conference

BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced that Bradford T. Smith, Executive Vice President, Corporate Affairs, and Andrew J. Conrad, Ph.D., Chief Scientist and Global Head of Clinical Trials for LabCorp, are scheduled to speak at the Bank of America 2008 Specialty Pharmaceuticals Conference in Southampton, NY. LabCorp’s presentation is planned for Friday, August 8, 2008 at 10:15 a.m. (Eastern Time).

MORE ON THIS TOPIC